[EN] 7-PHENYLALKYL SUBSTITUTED 2-QUINOLINONES AND 2 QUINOXALINONES AS POLY(ADP-RIBOSE) POLYMERASE INHIBITORS [FR] 2-QUINOLINONES ET 2 QUINOXALINONES A SUBSTITUTION 7-PHENYLALKYL TENANT LIEU D'INHIBITEURS DE POLY(ADP-RIBOSE) POLYMERASE INHIBITORS
A combination of an N‐heterocyclic carbene (NHC) ligand and a structurally simple surfactant has been realized, the hybrid surfactant–NHC. The related gold complex was synthesized, fully characterized, and applied in catalysis. This remarkably simple strategy allows, in combination with a co‐surfactant, the application of goldcatalysis in water.
7-PHENYLALKYL SUBSTITUTED 2-QUINOLINONES AND 2 QUINOXALINONES AS POLY(ADP-RIBOSE) POLYMERASE INHIBITORS
申请人:Janssen Pharmaceutica NV
公开号:EP1709011B1
公开(公告)日:2015-07-29
7-Phenylalkyl Substituted 2-Quinolinones and 2-Quinoxalinones as Poly(Adp-Ribose) Polymerase Inhibitors
申请人:Mabire Dominique Jean-Pierre
公开号:US20080249099A1
公开(公告)日:2008-10-09
The present invention provides compounds of formula (I), their use as PARP inhibitors as well as pharmaceutical compositions comprising said compounds of formula (I)
wherein n, R
1
, R
2
, R
3
, R
4
, R
5
, R
6
and X have defined meanings.
7-PHENYLALKYL SUBSTITUTED 2-QUINOLINONES AND 2-QUINOXALINONES AS POLY(ADP-RIBOSE) POLYMERASE INHIBITORS
申请人:Mabire Dominique Jean-Pierre
公开号:US20110230492A1
公开(公告)日:2011-09-22
The present invention provides compounds of formula (I), their use as PARP inhibitors as well as pharmaceutical compositions comprising said compounds of formula (I)
wherein n, R
1
, R
2
, R
3
, R
4
, R
5
, R
6
and X have defined meanings.